SAs soon as the Sars-CoV-2 genome was known, researchers from all continents embarked on an arms race against Covid-19. On the “upstream” front, that of vaccination, the success has been breathtaking: development and production speed records have been shattered. In less than a year, the first vaccine was ready. On the “downstream” side, that of treatments, the results are most mixed: two years of pandemic, a lot of trial and error and announcement effects. And often, much ado about nothing.
Paxlovid, the first “anti-Covid pill”
The therapeutic arsenal, however, timidly, is enriched. Since February 4, 2022, Paxlovid, an antiviral drug against Covid developed by Pfizer laboratories, has been available in community pharmacies. A…
The editorial staff advises you
